Vaccine-preventable diseases other than tuberculosis, and homelessness: A systematic review of the published literature, 1980 to 2020

Tran Duc Anh Ly, Sergei Castaneda, Van Thuan Hoang, Thi Loi Dao, Philippe Gautret
doi: https://doi.org/10.1101/2020.10.28.20220335

Abstract

Background Homelessness may result in the breakdown of regular health services, including routine vaccination programmes. A literature review was conducted to describe vaccine-preventable diseases (VPD) other than tuberculosis in homeless populations and to summarize vaccination recommendations in homeless people.

Methods We followed Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. We searched peer-reviewed literature published in English, French or Spanish reporting the outbreak of VPD or VPD prevalence in both infant and adult homeless populations published between 1980 and 2020, using PubMed/Medline, SciELO, Google Scholar, and Web of Science databases. Relevant information from the studies was charted in Microsoft Excel and results were summarised using a descriptive analytical method.

Results Seventy-five articles were included. A high prevalence of past HBV and HAV infections were observed through serosurveys, mostly in high income countries or high-middle income countries (USA, Canada, France, Iran or Brazil). Nine outbreaks of HAV infection were also reported, with lethality rates ranging from 0-4.8%. The studies discussed numerous risk factors positively associated with HBV infection, including older age, homosexual or bisexual practice, injected drug use (IDU), and, with HAV infection including IDU, having sexual partner(s) with a history of unspecified hepatitis, insertive anal penetration, or originating from a country with a high prevalence of anti-HAV antibody. Eleven outbreaks of pneumococcal infection affecting homeless persons were reported in Canada and USA, with lethality rates from 0-15.6%. Five diphtheria outbreaks were reported. Vaccination status was rarely documented in these studies.

Conclusions The literature suggests that homeless populations generally experience a higher VPD burden and lower immunisation rates. The findings suggest the need for a national vaccination programme and planning for delivering vaccines in this population.

1. Introduction

In addition to mental illness and unintentional injuries, homeless people are exposed to communicable diseases, which may lead to outbreaks that can become serious public health concerns [1]. High rates of infectious disease have been recorded in the literature among homeless people, including respiratory tract infections [2], gastrointestinal infections [3], skin infections, arthropod-borne diseases [4], and blood-borne and sexually transmitted infections [1].

The prevalence of these infectious diseases among the homeless varies greatly, depending on exposure factors. Generally, frequent alcohol and tobacco consumption or illicit drug use significantly impair the health status of homeless individuals [1]. Those sleeping on the street, outdoors in vehicles or in abandoned buildings are at high risk of food-borne disease (as the result of exposure to unhygienic environments) [3], human louse-transmitted disease [5], and of blood-borne and sexually transmitted infections (as the result of promiscuity and lack of hygiene, injected drug use and unprotected sexual practices) [6-7]. In addition, living in overcrowded accommodations, poor environmental conditions (poor ventilation, lack of sufficient food) and lack of continuity of care (omission of preventive measures, delayed diagnosis, interrupted or poor quality treatment) may increase vulnerability to infection, including transmissible disease. Consequently, when outbreaks occur in these settings, they spread rapidly, often with a high probability of prolonged transmission [1]. Evidence suggests that vaccination is still the most effective strategy for preventing infectious disease, resulting in significant reductions in illness, disability and death from several VPD [8]. Implementing routine vaccination may not only ensure long-term protection against VPD through the progressive increase of population immunity, limiting the number of preventable deaths among homeless people during an outbreak [3], but also protects vulnerable members of the general population who have not received all vaccines, such as the immunocompromised and the very young [9].

TB in homeless people has been extensively described in several recent review papers [10-13]. This scoping review of the published literature aims to describe an outbreak of VPD or VPD prevalence other than TB in both an infant and adult homeless population during the period 1980-2020. In addition, vaccination recommendations in homeless people were reviewed.

2. Materials and Methods

2.2 Search strategy

The systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (http://www.prisma-statement.org). Using Harzing’s Publish or Perish software (version 7.0), we searched the published literature from 1980 to 04 September 2020 in PubMed/Medline (in English), Scopus (in English), Web of Science databases (in English), SciELO (in English and Spanish), and Google Scholar (in French). Search strings were tailored to each database. Article references were scanned for additional articles. References were managed by Endnote software (version 9.3), and relevant information from the studies was charted in Microsoft Excel. Data table elements were created and were reviewed by all authors to ensure consistency of information extraction. Combinations of the following English search terms were used:

#1: “homeless” OR “homelessness” OR “street people”

#2: “diphtheria” OR “Corynebacterium diphtheriae” OR “tetanus” OR “Condyloma accuminata” OR “polio” OR “poliovirus” OR “poliomyelitis” OR “pertussis” OR “whooping cough” OR “Bordetella pertussis” OR “Haemophilus influenzae type b” OR “hepatitis B” OR “pneumococcal” OR “Streptococcus pneumoniae” OR “meningococcal” OR “meningococcus” OR “Neisseria meningitidis” OR “mumps” OR “measles” OR “rubella” OR “Human papillomavirus” OR “influenza” OR “flu” OR “hepatitis A” OR “shingles” OR “Varicella” OR “chickenpox” OR “typhoid” OR “Salmonella” OR “Rotavirus” OR “cholera” OR “Vibrio cholerae “OR “yellow fever” OR “rabies” OR “lyssaviruses” OR “Japanese encephalitis” OR “leptospirosis” OR “Leptospira”

#3: #1 AND #2

Combinations of the search terms in Spanish and French are shown in Supplementary data.

2.3 Inclusion and exclusion criteria

For inclusion, an article had to fulfil the following criteria: articles (1) written in English (focused language), French, Spanish, or Portuguese languages (if any); (2) published in peer-reviewed journals or unpublished data in our laboratory regarding the homeless population in Marseille, France; (3) reporting outbreaks of VPD or VPD prevalence in an infant or adult homeless population. Articles were excluded if the studies were reviews, case reports, or reported only vaccination rates. An additional manual search was conducted by reviewing reference lists of papers retrieved through the electronic search.

3. Results

As presented in Figure 1, the search identified a total of 9499 records, with an additional 2 records being unpublished data in our laboratory, resulting in 75 articles/reports that fulfilled the eligibility criteria (Figure 1). Seventy-one were written in English, one in French and two in Spanish. One article written in Portuguese was found when searching abstracts in English and was also included. The main findings of these articles are presented in Table 1.

View this table:
Table 1.

Hepatitis B infection among homeless persons identified through record review studies.

Figure 1.
Figure 1. Flow diagram of included and excluded records.

* Two unpublished data sets in our laboratory.

Hepatitis B (Table 1)

Forty-two hepatitis B articles reporting on vulnerable populations, notably including homeless people, were retrieved (including an unpublished data set) [6, 14-53]. Overall, 269,750 individuals were enrolled between 1988 and 2019. Thirty studies were conducted in adults (mean age: 25-49 years, range 16-86 years) [6, 14, 15, 17-25, 29-34, 37-40, 44-47, 49, 51-53], five studies were conducted in street youth (mean age:10-16 years, range 8-18 years) [16, 26-28, 51], and seven in both children and adults (mean age: 14-26 years, range 9-65 years) [35, 36, 41-43, 48, 50]. Studies were conducted in the USA (n=17) [14, 18, 33-35, 38, 40-47, 49, 52, 53], Iran (n=4) [6, 17, 21, 28], Canada [36, 48, 51], Brazil [19, 37, 50] France [15, 16] (including unpublished data), the UK [23, 25, 33], (n=3 per country), Australia [31], Costa Rica [24], Czech Republic [32], Germany [22], India [26], Ireland [29], Peru [20], Philippines [27] and Spain [39] (n=1 per country). Forty studies were seroprevalence surveys [6, 14-19, 21-42, 44-53]. The prevalence of anti-HBc antibodies ranged from 10.4% to 80.3% (past infection) and that of HBsAg ranged from 0.6% to 4.7% (ongoing infection). Two retrospective questionnaire surveys reported rates of 1.6% and 6% for HBV infection among participants [20, 43]. HBV infection among the homeless population was significantly higher than in non-homeless individuals included in the studies, or than in the general population, as assessed in studies conducted at the same period (n=14, including one unpublished data set) [16, 18, 19, 22, 31, 32, 36, 42, 47, 48, 51-53].

HBV infection among the homeless population was shown to be positively associated with older age [19, 42, 48], with homosexual or bisexual practices, having a sexual partner(s) with a history of unspecified hepatitis or insertive anal penetration [19, 42, 48], having black skin colour [19], reporting injected drug use (IDU) [6, 22-24, 29-33, 35, 38, 39, 41, 44, 48, 49], and alcohol use [33]. One study conducted among 189 homeless individuals in Australia reported that 6.3% of individuals with a past HBV infection also had a past hepatitis A (HAV) infection [31]. No hepatitis B–related deaths were reported. Five studies reported vaccination status against HBV infection through a questionnaire, with rates of 9%-54% (at least one dose) and 11.8%->66% (3 doses) [22, 30, 43, 44, 46, 48], and three studies showed immunisation rates of 21.8%-38.7% through serological tests [19, 23]. Anti-HBV vaccination was strongly recommended by all authors for high risk groups such as street youth or injected drug users (n=24 studies, including unpublished data) [15, 16, 19, 22, 23, 31, 32, 35-37, 39-44, 46-48, 50-53].

Hepatitis A (Table 2)

Seventeen hepatitis A articles conducted among homeless populations fulfilled the eligibility criteria [31, 35, 36, 54-67]. Overall, 10,552 individuals were enrolled between 1991 and 2018. Nine studies were conducted in adults (mean age: 19-45 years, range 16-74 years) [31, 55-57, 59, 61, 62, 64, 65], and eight in populations comprising children and adults (mean age: 25-42 years, range 0-90 years) [35, 36, 54, 58, 60, 63, 66, 67]. Studies were conducted in the USA (n=7) [35, 54, 56-68, 61, 64], Canada (n=4) [36, 55, 65, 66], Brazil [67], the UK [63], Czech Republic [60], The Netherlands [62], Iran [59] and Australia (n=1 per country) [31].

View this table:
Table 2.

Hepatitis A infection among homeless persons identified through record review studies.

Eight surveys addressed the seroprevalence of total anti-HAV antibodies among 6649 individuals: six revealed a high prevalence of 19.3%-69.7% among homeless persons in Brazil, Canada and the USA [31, 35, 36, 59, 64, 67], while two studies showed lower seroprevalence rates of 4.7%-6.3% among Canadian street youth, but with a high prevalence of risk factors for infection [65, 66]. Three studies reported risk factors for a high prevalence of HAV infection (reporting IDU, having sexual partner(s) with history of unspecified hepatitis, male subjects reporting insertive anal penetration or those originating from a country with a high anti-HAV prevalence) [35, 65, 66]. Other studies described nine outbreaks of Hepatitis A in several cities in the UK, The Netherlands, Czech republic and the USA; the numbers of confirmed cases in hospitals ranged from 42 to 1521 per outbreak (resulting in a total of 3903 outbreak-associated cases), with a high prevalence of 15.1%-78.0% being homeless persons [54-58, 60-63]. HAV-associated deaths ranged from 0-4.8% during outbreaks. Rates of co-infection with HAV and HBV (or HCV) were 3.0%, 6.3% and 34.0% in three studies [31, 55, 58]. No data about previous vaccination rates were available. Vaccination of homeless populations against HAV was strongly recommended in 15 studies [31, 35, 36, 54-56, 58, 60-67].

Pneumococcal infections (Table 3)

Thirteen studies concerning pneumococcal infections in homeless people were retrieved between 1988 and 2017 (including one unpublished data set) [2, 68-78]: 12 studies were conducted in adults (mean age: 19-54 years, range 16-78 years) and one in a population comprising children and adults (mean age: 42 years, range 0-90 years). Most studies were conducted in Canada (n=8) [68, 70-76], followed by France (n=3, including one unpublished data set) [2, 78], and the USA (n=2) [69, 77]. Two molecular prevalence surveys reported rates of 12.4% and 15.5% for pneumococcal nasopharyngeal carriage among a total of 575 sheltered homeless persons in Marseille, France between 2015-2018 (including one unpublished data set) [2], and prevalence was positively associated with respiratory symptoms and signs. Other studies described eleven outbreaks of invasive pneumococcal disease (IPD) occurring in different cities in Canada, the USA and France; of those, two studies reported 153 homeless individuals hospitalised with IPD, which accounted for 1.4%-8.4% of all homeless people present in two cities, Toronto (Canada) and Anchorage (USA) [76, 77]; nine other studies reported a high proportion (4.7%-48.8%) of homelessness among 4742 individuals hospitalised with IPD [68-75, 78]. Homeless individuals with IDP were typically younger [73, 77], more often male [73], smokers[73, 75, 76], alcohol abusers [73, 75, 77], illegal drug users [73, 75], and had a primary diagnosis of pneumonia [73], HIV infection or liver disease [76] when compared with non-homeless individuals. Of nine studies, two characterising the serotype of isolated Streptococcus pneumoniae strains showed that serotypes 1, 4, 5, 8 and 12F were positively associated with homelessness in Canada [68, 70, 72]. A serotype 1 IPD outbreak was reported among sheltered homeless individuals in Paris, France between 1988-1989 [78]. Serotype 4 outbreaks were also positively associated with homelessness in New Mexico, USA [69]. The mortality rate was 0%-15.6% among infected homeless people during outbreaks. By using a questionnaire, previous vaccination rates among the homeless population were reported to be 3.1%-37.0% (including one unpublished data set) [68, 70, 76, 78]. The pneumococcal vaccine was recommended for homeless populations in all articles.

View this table:
Table 3.

Other vaccine-preventable diseases among homeless persons identified through record review studies.

Diphtheria (Table 3)

Five diphtheria outbreak investigations were retrieved between 1972 and 2017. Overall, 1251 diphtheria cases were confirmed by culture (with a high prevalence of 12.0%-95.0% cases being homeless persons) [79-83]. Three studies were conducted in adults (mean age: 40-45 years, range 16-71 years) [79-81], and two in both children and adults (mean age: 37-38 years, range 4-87 years) [82, 83]. An early investigation conducted in Seattle, USA between 1972-1982 reported an outbreak of respiratory and cutaneous infections among 1100 patients, including 95% homeless individuals [83]. Molecular studies performed in different types of samples (details not provided) collected in Germany and Poland showed a high 53.9%-100% prevalence of genotype ST8 [79, 80]. One study conducted in Switzerland, Germany and France between 1996-1997 reported 17 cases with cutaneous infection [81]. One study conducted in France between 1987-1993 reported 40 patients with systemic infection [82].

Several risk factors for diphtheria infection were identified, including alcohol abuse [79-81, 83], poor hygiene, crowding conditions, contaminated fomites, underlying skin disease, hyperendemic streptococcal pyoderma, and introduction of new strains from exogenous reservoirs [83]. Death from diphtheria was reported in two studies, with 0.9%-36.0% lethality rates [82, 83]. No data about previous vaccination status was available. One study recommended the need for vaccination boosters in alcoholic homeless persons [83].

Seasonal influenza (Table 3)

Four PCR-based prevalence surveys conducted among 1103 homeless or persons from marginalised populations between 2005 and 2018 fulfilled the eligibility criteria [2, 15, 84, 85]. Three were conducted among adult sheltered homeless persons in Marseille, France, and one was conducted among marginalised populations, including homeless persons, in Tijuana, Mexico. Three studies were conducted in adults (mean age: 35-44 years, range 18-84 years) [2, 15, 84] and one in a population comprising children and adults (mean age: 41 years, range 7-76 years) [85]. These studies reported a 1.0-3.0% rate of influenza nasopharyngeal carriage among sheltered homeless persons. Using a questionnaire, the previous seasonal influenza vaccination rate among the homeless population was 9.0%-15.0%. The rate of co-infection with S. pneumoniae and influenza viruses was 0.2% among homeless individuals in Marseille, France [2]. No influenza deaths were reported. All authors recommended vaccination against influenza for homeless people.

Human papillomavirus (HPV) infection (Table 3)

Only two American studies concerning HPV infection fulfilled the eligibility criteria. They were conducted in young adults (range 16-29 years) [46, 86]. One molecular prevalence survey was conducted among 130 men having sex with men, of whom 22.6% were homeless and 75% had at least one high-risk HPV type [86]. Another epidemiological study using Pap smear testing in 2960 young female homeless persons revealed a 2.0% rate of HPV infection [46]. Information about vaccination rates was not recorded. No deaths were reported. The vaccination against HPV-16 was recommended for homeless men who have sex with men [86].

Other VPD

No reports about measles, tetanus, poliomyelitis, pertussis, H. influenzae type b infection, meningococcal C infection, mumps, rubella, varicella, chickenpox, typhoid fever, rotavirus infection, cholera, yellow fever, lyssaviruses, rabies, Japanese encephalitis and leptospirosis among homeless people were retrieved.

4. Discussion

This review shows that the four most frequent VPD among homeless people are HBV infection, HAV infection, IPD, and diphtheria.

High rates of HBV and HAV infection in homeless persons were observed through serological surveys in low endemicity countries, including the USA, Canada, France and in moderate endemicity countries such as Iran and Brazil. Outbreaks of HAV infection were reported in the US. Currently, three modes of HBV transmission have been recognised: perinatal, sexual and parenteral/percutaneous transmission [87], whilst acute HAV is a highly contagious infection resulting from faeco-oral transmission and has been one of the major aetiologies for foodborne disease [88]. Homeless persons, notably those using injected drugs and having at-risk sexual practices should therefore benefit from vaccination against HBV and HAV infections, together with the provision of injection kits, drug substitutes and condoms.

Outbreaks of IPD were reported in homeless persons in Canada, and several risk factors were identified, including smoking, alcohol abuse, illegal drug use and having several chronic diseases. Given that the serotypes attributable to these outbreaks (1, 4, 5, 8, 12F) are among those included in the 23-valent pneumococcal polysaccharide vaccine, vaccination of homeless people against IPD should be considered, notably when presenting with risk factors.

Finally, because of several diphtheria outbreaks occurring among homeless persons, updating vaccination against this disease should be also considered in this population, as in the general population.

To the best of our knowledge, specific vaccination recommendations for homeless people in national guidelines have been made in only two countries. The 23-valent pneumococcal polysaccharide vaccine (PPSV23) was recommended early in 2008 by the Canadian National Advisory Committee on Immunization (NACI) for all homeless people. In the USA, the adult immunisation schedule [89], updated annually by the Advisory Committee on Immunization Practices (ACIP), has recommended HAV vaccination for all homeless individuals aged > 1 year since October 2018 [3].

In France, the Ministry of Solidarity and Health (Table 4) recommends HAV vaccination for: children aged > 1 year having at least one family member originating from a country with a high prevalence of anti-HAV antibody, for patients with cystic fibrosis or liver disease (notably viral hepatitis and alcohol abuse), for institutionalised infants or young disabled persons, for men having sex with men, for professionals exposed to HAV or involved in collective food preparation and for travellers to endemic areas. For HBV, IPD, and diphtheria, primary vaccination is recommended for all children. The HBV vaccination is notably recommended for institutionalised infants or young disabled persons, for persons in psychiatric institutions, for those with at-risk sexual practices, those using injected drugs or having chronic liver disease or HIV infection, for those with at least one family member with HBV infection, for detained persons, for professionals exposed to HBV (notably health care professionals) and for travellers to endemic areas [90]. PPSV23 together with PCV13 (13-valent pneumococcal conjugate vaccine) is especially recommended for those with several chronic conditions (HIV infection, chronic respiratory disease, heart failure, etc.). No specific recommendations concerning diphtheria vaccination are given for high risk groups other than professionals.

View this table:
Table 4.

Summary of vaccination against HAV, HBV, pneumococcus and diphtheria for French children and adults1

Delivering vaccines to homeless populations has always been a challenge. Combining easy access and education is probably the best approach to vaccination administration programmes in this population. We suggest making vaccines available at homeless shelters or homeless restaurants through medical or paramedical staff. For homeless IDU, the availability of vaccines at syringe-exchange sites could provide more opportunities for them to access vaccination [44]. Additionally, we also suggest applying a rapid serological testing strategy in areas where homeless persons tend to aggregate, including HBsAg detection (for HBV) [91] and IgM/IgG anti-HAV, since a substantial proportion of individuals may already have antibodies against these infections due to past exposure to the viruses or previous vaccination.

Because this review was restricted to articles written in general languages such as English, Spanish and French, the data collected are mainly from the North American and European continents. Limitations include the possible lack of articles from Asian and African regions. Despite these limitations, our review showed that implementation of vaccination coverage against communicable diseases in the homeless is a major public health priority. We strongly recommend updating vaccination against HAV, HBV, pneumococcal infection and diphtheria in homeless persons when entering homeless shelters or whenever they are present in a healthcare setting, rather than as a response measure to prevent outbreaks after the first case has occurred.

Data Availability

Not applicable

Funding

No funding.

Conflicts of interest/Competing interests

The authors have no conflicts of interest.

Author contributions

TD, VT, TL and PG contributed to data analysis, English or French article reading, interpretation and writing. SC contributed to Spanish article reading, interpretation and writing. PG coordinated the work.

References (91/100)

  1. [1].↵
    Badiaga S, Raoult D, Brouqui P. Preventing and controlling emerging and reemerging transmissible diseases in the homeless. Emerg Infect Dis 2008; 14(9):1353–9. http://doi.org/10.3201/eid1409.080204.
    OpenUrlCrossRefPubMed
  2. [2].↵
    Ly TDA, Edouard S, Badiaga S, Tissot-Dupont H, Hoang VT, Pommier de Santi V, et al. Epidemiology of respiratory pathogen carriage in the homeless population within two shelters in Marseille, France, 2015-2017: cross sectional 1-day surveys. Clin Microbiol Infect 2019; 25(2):p249.e1–249.e6. http://doi.org/10.1016/j.cmi.2018.04.032.
    OpenUrl
  3. [3].↵
    Doshani M, Weng M, Moore KL, Romero JR, Nelson NP. Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness. MMWR Morb Mortal Wkly Rep 2019; 68(6):153–156. http://doi.org/10.15585/mmwr.mm6806a6.
    OpenUrl
  4. [4].↵
    Brouqui P, Raoult D. Arthropod-borne diseases in homeless. Ann N Y Acad Sci 2006; 1078:223–235. http://doi.org/10.1196/annals.1374.041.
    OpenUrlCrossRefPubMedWeb of Science
  5. [5].↵
    World Health Organization. A global brief on vector-borne diseases, https://apps.who.int/iris/handle/10665/111008; 2008 [accessed 20 September 2020].
  6. [6].↵
    Vahdani P, Hosseini-Moghaddam SM, Family A, Moheb-Dezfouli R. Prevalence of HBV, HCV, HIV and syphilis among homeless subjects older than fifteen years in Tehran. Arch Iran Med 2009; 12(5):483–487.
    OpenUrlPubMed
  7. [7].↵
    Robertson MJ, Cousineau MR. Health status and access to health services among the urban homeless. Am J Public Health 1986;76:561–563.
    OpenUrlCrossRefPubMedWeb of Science
  8. [8].↵
    Andre FA, R Booy, HL Bock, J Clemens, SK Datta, TJ John, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide, https://www.who.int/bulletin/volumes/86/2/07-040089/en/; 2008 [accessed 20 September 2020].
  9. [9].↵
    Borba RC, Vidal VM, Moreira LO. The re-emergency and persistence of vaccine preventable diseases. An Acad Bras Cienc 2015; 87(2 Suppl):1311–1322. http://doi.org/10.1590/0001-3765201520140663.
    OpenUrl
  10. [10].↵
    Hamilton K, Tolfree R, Mytton J. A systematic review of active case-finding strategies for tuberculosis in homeless populations. Int J Tuberc Lung Dis 2018; 22(10):1135–1144. http://doi.org/10.5588/ijtld.17.0784.
    OpenUrl
  11. [11].
    Heuvelings CC, Greve PF, de Vries SG, Visser BJ, Bélard S, Janssen S, et al. Effectiveness of service models and organisational structures supporting tuberculosis identification and management in hard-to-reach populations in countries of low and medium tuberculosis incidence: a systematic review. BMJ Open 2018; 8(9):e019642. http://doi.org/10.1136/bmjopen-2017-019642.
    OpenUrlAbstract/FREE Full Text
  12. [12].
    Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis. BMC Public Health 2018;18(1):485. http://doi.org/10.1186/s12889-018-5393-x.
    OpenUrl
  13. [13].↵
    Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 2015;4 6(6):1563–1576. http://doi.org/10.1183/13993003.01245-2015.
    OpenUrl
  14. [14].↵
    Fuster D, Gelberg L. Community Screening, Identification, and Referral to Primary Care, for Hepatitis C, B, and HIV Among Homeless Persons in Los Angeles. J Community Health 2019; 44(6):1044–1054. http://doi.org/10.1007/s10900-019-00679-w.
    OpenUrl
  15. [15].↵
    Ly TDA, Dao TL, Hoang VT, Braunstein D, Brouqui P, Lagier JC, et al. Pattern of infections in French and migrant homeless hospitalised at Marseille infectious disease units, France: A retrospective study, 2017-2018. Travel Med Infect Dis 2020:101768. http://doi.org/10.1016/j.tmaid.2020.101768.
  16. [16].↵
    Legoupil C, Peltier A, Henry Kagan V, Segouin C, Alberti C, de Massé L, et al. Out-of-Hospital screening for HIV, HBV, HCV and Syphilis in a vulnerable population, a public health challenge. AIDS Care 2017; 29(6):686–688. http://doi.org/10.1080/09540121.2016.1231886.
    OpenUrl
  17. [17].↵
    Doosti-Irani A, Mokhaeri H, Chegini Sharafi A, Aghasadeghi MR, Hajimiragha M, Saki M, et al. Prevalence of HIV, HBV, and HCV and Related Risk Factors amongst Male Homeless People in Lorestan Province, the West of Iran. J Res Health Sci 2017; 17(1):e00373.
    OpenUrl
  18. [18].↵
    Noska AJ, Belperio PS, Loomis TP, O’Toole TP, Backus LI. Prevalence of Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Among Homeless and Nonhomeless United States Veterans. Clin Infect Dis 2017; 65(2):252–258. http://doi.org/10.1093/cid/cix295.
    OpenUrl
  19. [19].↵
    Carvalho PMRDS, Matos MA, Martins RMB, Pinheiro RS, Caetano KAA, Souza MM, et al. Prevalence, risk factors and hepatitis B immunization: helping fill the gap on hepatitis B epidemiology among homeless people, Goiânia, Central Brazil. Cad Saude Publica 2017;33(7):e00109216. http://doi.org/10.1590/0102-311X00109216.
    OpenUrl
  20. [20].↵
    Moquillaza-Risco M, León E, Dongo M, Munayco CV. Características sociodemográficas y de salud de los adultos mayores en situación de calle en Lima, Perú. Rev Peru Med Exp Salud Pública 2015; 32:693–700.
    OpenUrl
  21. [21].↵
    Foroughi M, Moayedi-Nia S, Shoghli A, Bayanolhagh S, Sedaghat A, Mohajeri M, et al. Prevalence of HIV, HBV and HCV among street and labour children in Tehran, Iran. Sex Transm Infect. 2017;93(6):421–423. http://doi.org/10.1136/sextrans-2016-052557.
    OpenUrlAbstract/FREE Full Text
  22. [22].↵
    Haussig JM, Nielsen S, Gassowski M, Bremer V, Marcus U, Wenz B, et al. A large proportion of people who inject drugs are susceptible to hepatitis B: Results from a bio-behavioural study in eight German cities. Int J Infect Dis 2018; 66:5–13. http://doi.org/10.1016/j.ijid.2017.10.008.
    OpenUrl
  23. [23].↵
    Aldridge RW, Story A, Hwang SW, Nordentoft M, Luchenski SA, Hartwell G, et al. Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis. Lancet 2018; 391(10117):241–250. http://doi.org/10.1016/S0140-6736(17)31869-X.
    OpenUrlCrossRefPubMed
  24. [24].↵
    Leiva-Hidalgo J, Madrigal-Méndez A, Salas-Segura D. Seroprevalence of Heptatis B, C and VIH en Homeless People in Costa Rica. Rev Costarric Salud Pública 2013; 22:113–118.
    OpenUrl
  25. [25].↵
    Craine N, Hickman M, Parry JV, Smith J, McDonald T, Lyons M. Characteristics of injecting drug users accessing different types of needle and syringe programme or using secondary distribution. J Public Health (Oxf); 32(3):328–235. http://doi.org/10.1093/pubmed/fdp131.
  26. [26].↵
    Bal B, Mitra R, Mallick AH, Chakraborti S, Sarkar K. Nontobacco substance use, sexual abuse, HIV, and sexually transmitted infection among street children in Kolkata, India. Subst Use Misuse 2010; 45(10):1668–1682. http://doi.org/10.3109/10826081003674856.
    OpenUrlPubMed
  27. [27].↵
    Njord L, Merrill RM, Njord R, Pachano JD, Hackett A. Characterizing health behaviors and infectious disease prevalence among Filipino street children. Int J Adolesc Med Health 2008;20(3):367–374. http://doi.org/10.1515/ijamh.2008.20.3.367.
  28. [28].↵
    Vahdani P, Hosseini-Moghaddam SM, Gachkar L, Sharafi K. Prevalence of hepatitis B, hepatitis C, human immunodeficiency virus, and syphilis among street children residing in southern Tehran, Iran. Arch Iran Med 2006; 9(2):153–155.
    OpenUrlPubMed
  29. [29].↵
    O’Carroll A, O’Reilly F. Health of the homeless in Dublin: has anything changed in the context of Ireland’s economic boom? Eur J Public Health. 2008; 18(5):448–453. http://doi.org/10.1093/eurpub/ckn038.
    OpenUrlCrossRefPubMedWeb of Science
  30. [30].↵
    Lyons M, Walker M, Craine N, Smith J. Incidence of blood borne viral hepatitis in injecting drug users in South Wales: a de-linked prospective cohort study. National Public Health Service for Wales 2006; 16–19.
  31. [31].↵
    Poulos R, Ferson M, Orr K, Lucy A, Botham S, McCarthy M, Stern J, Dixon J, Murray C, Polis S. Risk factors and seroprevalence of markers for hepatitis A, B and C in persons subject to homelessness in inner Sydney. Aust N Z J Public Health. 2007; 31(3):247–51. http://doi.org/10.1111/j.1467-842x.2007.00056.x.
    OpenUrlCrossRefPubMed
  32. [32].↵
    Stein JA, Andersen RM, Robertson M, Gelberg L. Impact of hepatitis B and C infection on health services utilization in homeless adults: a test of the Gelberg-Andersen Behavioral Model for Vulnerable Populations. Health Psychol 2012; 31(1):20–30. http://doi.org/10.1037/a0023643.
    OpenUrlCrossRefPubMedWeb of Science
  33. [33].↵
    Volf V, Marx D, Pliskova L, Sümegh L, Celko A. A survey of hepatitis B and C prevalence amongst the homeless community of Prague. Eur J Public Health. 2008;18(1):44–47. http://doi.org/10.1093/eurpub/ckm072.
    OpenUrlCrossRefPubMedWeb of Science
  34. [34].↵
    Boyce DE, Tice AD, Ona FV, Akinaka KT, Lusk H. Viral hepatitis in a homeless shelter in Hawai’i. Hawaii Med J 2009;68(5):113–115.
    OpenUrlPubMed
  35. [35].↵
    Garfein RS, Swartzendruber A, Ouellet LJ, Kapadia F, Hudson SM, Thiede H, et al. Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). Drug Alcohol Depend 2007;91 Suppl 1:S4–17. http://doi.org/10.1016/j.drugalcdep.2007.05.007.
    OpenUrlCrossRefPubMedWeb of Science
  36. [36].↵
    Moses S, Mestery K, Kaita KD, Minuk GY. Viral hepatitis in a Canadian street-involved population. Can J Public Health. 2002;93(2):123–128.
    OpenUrlPubMedWeb of Science
  37. [37].↵
    Brito VO, Parra D, Facchini R, Buchalla CM. [HIV infection, hepatitis B and C and syphilis in homeless people, in the city of São Paulo, Brazil]. Rev Saude Publica 2007; 41 Suppl 2:47–56. Portuguese.
    OpenUrlPubMed
  38. [38].↵
    Harris HW, Young DM. Care of injection drug users with soft tissue infections in San Francisco, California. Arch Surg 2002; 137(11):1217–1222. http://doi.org/doi:10.1001/archsurg.137.11.1217.
    OpenUrlCrossRefPubMedWeb of Science
  39. [39].↵
    Vallejo F, Toro C, de la Fuente L, Brugal MT, Soriano V, Silva TC, et al. Prevalence of and risk factors for hepatitis B virus infection among street-recruited young injection and non-injection heroin users in Barcelona, Madrid and Seville. Eur Addict Res 2008;14(3):116–24. http://doi.org/10.1159/000130415.
    OpenUrlPubMed
  40. [40].↵
    Klinkenberg WD, Caslyn RJ, Morse GA, Yonker RD, McCudden S, Ketema F, et al. Prevalence of human immunodeficiency virus, hepatitis B, and hepatitis C among homeless persons with co-occurring severe mental illness and substance use disorders. Compr Psychiatry 2003; 44:293–302. http://doi.org/10.1016/S0010-440X(03)00094-4.
    OpenUrlCrossRefPubMedWeb of Science
  41. [41].↵
    Noell J, Rohde P, Ochs L, Yovanoff P, Alter MJ, Schmid S, Bullard J, Black C. Incidence and prevalence of chlamydia, herpes, and viral hepatitis in a homeless adolescent population. Sex Transm Dis 2001; 28(1):4–10. http://doi.org/doi:10.1097/00007435-200101000-00003.
    OpenUrlCrossRefPubMedWeb of Science
  42. [42].↵
    Beech BM, Myers L, Beech DJ, Kernick NS. Human immunodeficiency syndrome and hepatitis B and C infections among homeless adolescents. Semin Pediatr Infect Dis 2003;14(1):12–9.
    OpenUrlCrossRefPubMed
  43. [43].↵
    Lifson AR, Halcón LL. Substance abuse and high-risk needle-related behaviors among homeless youth in Minneapolis: implications for prevention. J Urban Health 2001; 78(4):690–698. http://doi.org/10.1093/jurban/78.4.690.
    OpenUrlPubMedWeb of Science
  44. [44].↵
    Altice FL, Bruce RD, Walton MR, Buitrago MI. Adherence to hepatitis B virus vaccination at syringe exchange sites. J Urban Health 2005; 82(1):151–161. http://doi.org/10.1093/jurban/jti016.
    OpenUrlCrossRefPubMedWeb of Science
  45. [45].
    Cheung RC, Hanson AK, Maganti K, Keeffe EB, Matsui SM. Viral hepatitis and other infectious diseases in a homeless population. J Clin Gastroenterol 2002; 34(4):476–80. http://doi.org/10.1097/00004836-200204000-00021.
    OpenUrlCrossRefPubMedWeb of Science
  46. [46].↵
    Steele RW, Ramgoolam A, Evans J Jr. Health services for homeless adolescents. Semin Pediatr Infect Dis 2003; 14(1):38–42. http://doi.org/10.1053/spid.2003.127216.
    OpenUrlPubMed
  47. [47].↵
    Alderman EM, Shapiro A, Spigland I, Coupey SM, Bashir M, Fox AS. Are there risk factors for hepatitis B infection in inner-city adolescents that justify prevaccination screening? J Adolesc Health 1998; 22(5):389–393.
    OpenUrlPubMed
  48. [48].↵
    Roy E, Haley N, Lemire N, Boivin JF, Leclerc P, Vincelette J. Hepatitis B virus infection among street youths in Montreal. CMAJ 1999; 161(6):689–693.
    OpenUrlAbstract/FREE Full Text
  49. [49].↵
    López-Zetina J, Kerndt P, Ford W, Woerhle T, Weber M. Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1996. Addiction 2001;96(4):589–95. http://doi.org/10.1080/09652140020031638.
    OpenUrlCrossRefPubMedWeb of Science
  50. [50].↵
    Porto SO, Cardoso DD, Queiróz DA, Rosa H, Andrade AL, Zicker F, Martelli CM. Prevalence and risk factors for HBV infection among street youth in central Brazil. J Adolesc Health. 1994 Nov;15(7):577–81.
    OpenUrlCrossRefPubMedWeb of Science
  51. [51].↵
    Wang EE, King S, Goldberg E, Bock B, Milner R, Read S. Hepatitis B and human immunodeficiency virus infection in street youths in Toronto, Canada. Pediatr Infect Dis J 1991;10(2):130–133.
    OpenUrlCrossRefPubMedWeb of Science
  52. [52].↵
    McMahon BJ, Wainwright K, Bulkow L, Parkinson AJ, Lindenbaum M, Wainwright R, Helminiak C. Response to hepatitis B vaccine in Alaska natives with chronic alcoholism compared with non-alcoholic control subjects. Am J Med 1990; 88(5):460–464. http://doi.org/10.1016/0002-9343(90)90423-b.
    OpenUrlPubMed
  53. [53].↵
    Gelberg L, Robertson MJ, Leake B, Wenzel SL, Bakhtiar L, Hardie EA, et al. Hepatitis B among homeless and other impoverished US military veterans in residential care in Los Angeles. Public Health 2001; 115(4):286–291. http://doi.org/10.1038/sj/ph/1900783. PMID: 11464302.
    OpenUrlPubMed
  54. [54].↵
    Wilson E, Hofmeister MG, McBee S, Briscoe J, Thomasson E, Olaisen RH, et al. Hepatitis A Outbreak Associated with Drug Use and Homelessness — West Virginia, 2018. MMWR Morb Mortal Wkly Rep 2019; 68(14);330–331.
    OpenUrl
  55. [55].↵
    Sachdeva H, Benusic M, Ota S, Stuart R, Maclachlan J, Dubey V, Andonov A. Community outbreak of hepatitis A disproportionately affecting men who have sex with men in Toronto, Canada, January 2017-November 2018. Can Commun Dis Rep 2019; 45(10):262–268. http://doi.org/10.14745/ccdr.v45i10a03.
    OpenUrl
  56. [56].↵
    Peak CM, Stous SS, Healy JM, Hofmeister MG, Lin Y, Ramachandran S, Foster M, Kao A, McDonald EC. Homelessness and Hepatitis A - San Diego County, 2016-2018. Clin Infect Dis 2019; pii:ciz788. http://doi.org/10.1093/cid/ciz788.
  57. [57].↵
    Kreshak AA, Brennan JJ, Vilke GM, Tolia VM, Caccese M, Castillo EM, et al. A Description of a Health System’s Emergency Department Patients Who Were Part of a Large Hepatitis A Outbreak. J Emerg Med. 2018; 55(5):620–626. http://doi.org/10.1016/j.jemermed.2018.07.031.
    OpenUrl
  58. [58].↵
    Foster M, Ramachandran S, Myatt K, Donovan D, Bohm S, Fiedler J, et al. Hepatitis A Virus Outbreaks Associated with Drug Use and Homelessness - California, Kentucky, Michigan, and Utah, 2017. MMWR Morb Mortal Wkly Rep 2018; 67(43):1208–1210. http://doi.org/10.15585/mmwr.mm6743a3.
    OpenUrlCrossRef
  59. [59].↵
    Jahanbakhsh F, Bagheri Amiri F, Sedaghat A, Fahimfar N, Mostafavi E. Prevalence of HAV Ab, HEV (IgG), HSV2 IgG, and Syphilis Among Sheltered Homeless Adults in Tehran, 2012. Int J Health Policy Manag 2018;7(3):225–230. http://doi.org/10.15171/ijhpm.2017.74.
    OpenUrl
  60. [60].↵
    Fabianova K, Cástková J, Beneš C, Kyncl J, Kriz B. Increase in hepatitis A cases in the Czech Republic in 2008 - preliminary report. Eurosurveillance 2008:13(40).
  61. [61].↵
    James TL, Aschkenasy M, Eliseo LJ, Olshaker J, Mehta SD. Response to hepatitis A epidemic: emergency department collaboration with public health commission. J Emerg Med 2009; 36(4):412-6. http://doi.org/10.1016/j.jemermed.2007.10.001.
    OpenUrlPubMed
  62. [62].↵
    Tjon GM, Götz H, Koek AG, de Zwart O, Mertens PL, Coutinho RA. An outbreak of hepatitis A among homeless drug users in Rotterdam, The Netherlands. J Med Virol 2005; 77(3):360-366.
    OpenUrlCrossRefPubMed
  63. [63].↵
    Syed NA, Hearing SD, Shaw IS, Probert CS, Brooklyn TN, Caul EO, et al. Outbreak of hepatitis A in the injecting drug user and homeless populations in Bristol: control by a targeted vaccination programme and possible parenteral transmission. Eur J Gastroenterol Hepatol 2003; 15(8):901-906.
    OpenUrlCrossRefPubMed
  64. [64].↵
    Hennessey KA, Bangsberg DR, Weinbaum C, Hahn JA. Hepatitis A seroprevalence and risk factors among homeless adults in San Francisco: should homelessness be included in the risk-based strategy for vaccination? Public Health Rep 2009; 124(6):813-817.
    OpenUrlCrossRef
  65. [65].↵
    Ochnio JJ, Patrick D, Ho M, Talling DN, Dobson SR. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs. CMAJ 2001; 165(3):293-297.
    OpenUrlAbstract/FREE Full Text
  66. [66].↵
    Roy E, Haley N, Leclerc P, Cédras L, Bédard L, Allard R. Seroprevalence and risk factors for hepatitis A among Montreal street youth. Can J Public Health 2002; 93(1):52-53. Erratum in: Can J Public Health 2002; 93(3):232.
    OpenUrl
  67. [67].↵
    Queiróz DA, Cardoso DD, Martelli CM, Martins RM, Porto SO, Azevedo MS, et al. [Seroepidemiology of hepatitis A virus infection in street children of Goiânia-Goiás]. Rev Soc Bras Med Trop 1995; 28(3):199-203. Portuguese.
    OpenUrlCrossRefPubMed
  68. [68].↵
    McKee G, Choi A, Madill C, Marriott J, Kibsey P, Hoyano D. Outbreak of invasive Streptococcus pneumoniae among an inner-city population in Victoria, British Columbia, 2016-2017. Can Commun Dis Rep 2018; 44(12):317-322. http://doi.org/10.14745/ccdr.v44i12a02.
    OpenUrl
  69. [69].↵
    Beall B, Walker H, Tran T, Li Z, Varghese J, McGee L, et al. Upsurge of conjugate vaccine serotype 4 invasive pneumococcal disease clusters among adults experiencing homelessness in California, Colorado, and New Mexico. J Infect Dis 2020 http://doi.org/10.1093/infdis/jiaa501.
  70. [70].↵
    Schillberg E, Isaac M, Deng X, Peirano G, Wylie JL, Van Caeseele P, et al. Outbreak of invasive Streptococcus pneumoniae serotype 12F among a marginalized inner-city population in Winnipeg, Canada, 2009-2011. Clin Infect Dis; 59(5):651–657. http://doi.org/10.1093/cid/ciu366.
    OpenUrl
  71. [71].
    Tyrrell GJ, Lovgren M, Ibrahim Q, Garg S, Chui L, Boone TJ, Mangan C, Patrick DM, Hoang L, Horsman GB, Van Caeseele P, Marrie TJ. Epidemic of invasive pneumococcal disease, western Canada, 2005-2009. Emerg Infect Dis 2012; 18(5):733-740. http://doi.org/10.3201/eid1805.110235.
    OpenUrlCrossRefPubMed
  72. [72].↵
    Vanderkooi OG, Church DL, MacDonald J, Zucol F, Kellner JD. Community-based outbreaks in vulnerable populations of invasive infections caused by Streptococcus pneumoniae serotypes 5 and 8 in Calgary, Canada. PLoS One 2011; 6(12):e28547. http://doi.org/10.1371/journal.pone.0028547.
    OpenUrlCrossRefPubMed
  73. [73].↵
    Lemay JA, Ricketson LJ, Zwicker L, Kellner JD. Homelessness in Adults with Invasive Pneumococcal Disease (IPD) in Calgary, Canada. Open Forum Infect Dis 2019; 6(10). pii: ofz362. http://doi.org/10.1093/ofid/ofz362.
  74. [74].
    Marrie TJ, Tyrrell GJ, Majumdar SR, Eurich DT. Invasive Pneumococcal Disease: Still Lots to Learn and a Need for Standardized Data Collection Instruments. Can Respir J 2017; 2017:2397429. http://doi.org/10.1155/2017/2397429.
    OpenUrl
  75. [75].↵
    Shariatzadeh MR, Huang JQ, Tyrrell GJ, Johnson MM, Marrie TJ. Bacteremic pneumococcal pneumonia: a prospective study in Edmonton and neighboring municipalities. Medicine (Baltimore). 2005; 84(3):147–161.
    OpenUrlCrossRefPubMed
  76. [76].↵
    Plevneshi A, Svoboda T, Armstrong I, Tyrrell GJ, Miranda A, Green K, Low D, McGeer A; Toronto Invasive Bacterial Diseases Network. Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS One 2009; 4(9):e7255.
    OpenUrlCrossRefPubMed
  77. [77].↵
    Mosites E, Zulz T, Bruden D, Nolen L, Frick A, Castrodale L, McLaughlin J, Van Beneden C, Hennessy TW, Bruce MG. Risk for Invasive Streptococcal Infections among Adults Experiencing Homelessness, Anchorage, Alaska, USA, 2002-2015. Emerg Infect Dis 2019; 25(10). http://doi.org/10.3201/eid2510.181408.
  78. [78].↵
    Mercat A, Nguyen J, Dautzenberg B. An outbreak of pneumococcal pneumonia in two men’s shelters. Chest 1991; 99(1):147–151.
    OpenUrlCrossRefPubMedWeb of Science
  79. [79].↵
    Dangel A, Berger A, Konrad R, Bischoff H, Sing A. Geographically Diverse Clusters of Nontoxigenic Corynebacterium diphtheriae Infection, Germany, 2016-2017. Emerg Infect Dis 2018; 24(7):1239–1245. http://doi.org/10.3201/eid2407.172026.
    OpenUrlCrossRef
  80. [80].↵
    Zasada AA. Nontoxigenic highly pathogenic clone of Corynebacterium diphtheriae, Poland, 2004-2012. Emerg Infect Dis. 2013; 19(11):1870–1972. http://doi.org/10.3201/eid1911.130297.
    OpenUrlCrossRef
  81. [81].↵
    Funke G, Altwegg M, Frommelt L, von Graevenitz A. Emergence of related nontoxigenic Corynebacterium diphtheriae biotype mitis strains in Western Europe. Emerg Infect Dis 1999; 5(3):477–780. http://doi.org/10.3201/eid0503.990326.
    OpenUrlCrossRefPubMed
  82. [82].↵
    Patey O, Bimet F, Riegel P, Halioua B, Emond JP, Estrangin E, et al. Clinical and molecular study of Corynebacterium diphtheriae systemic infections in France. Coryne Study Group. J Clin Microbiol 1997; 35(2):441–445
    OpenUrl
  83. [83].↵
    Harnisch JP, Tronca E, Nolan CM, Turck M, Holmes KK. Diphtheria among alcoholic urban adults. A decade of experience in Seattle. Ann Intern Med 1989; 111(1):71–82. http://doi.org/10.7326/0003-4819-111-1-71.
    OpenUrlCrossRefPubMedWeb of Science
  84. [84].↵
    Rodwell TC, Robertson AM, Aguirre N, Vera A, Anderson CM, Lozada R, et al. Pandemic (H1N1) 2009 Surveillance in Marginalized Populations, Tijuana, Mexico. Emerg Infect Dis 2010;16(8):1292–5. http://doi.org/10.3201/eid1608.100196.
    OpenUrlCrossRefPubMed
  85. [85].↵
    Badiaga S, Richet H, Azas P, Zandotti C, Rey F, Charrel R, et al. Contribution of a shelter-based survey for screening respiratory diseases in the homeless. Eur J Public Health 2009;19(2):157–60. http://doi.org/10.1093/eurpub/ckn142.
    OpenUrlCrossRefPubMedWeb of Science
  86. [86].↵
    Nyitray AG, Fujimoto K, Zhao J, Giuliano AR, Schneider JA, Hwang LY. Prevalence of and Risk Factors for Anal Human Papillomavirus Infection in a Sample of Young, Predominantly Black Men Who Have Sex With Men, Houston, Texas. J Infect Dis 2018;217(5):777–784.
    OpenUrl
  87. [87].↵
    Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci. 2005;2(1):50–57. http://doi.org/10.7150/ijms.2.50.
    OpenUrlPubMed
  88. [88].↵
    Havelaar AH, Kirk MD, Torgerson PR, Gibb HJ, Hald T, Lake RJ, et al. World Health Organization global estimates and regional comparisons of the burden of foodborne disease in 2010. PLoS Med 2015; 12:e1001923.
    OpenUrlCrossRefPubMed
  89. [89].↵
    Centers for Disease control and Prevention. Adult immunization Schedule, https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf; 2020 [accessed 20 September 2020].
  90. [90].↵
    Ministère des solidarité et de la santé. Calendrier des vaccinations et recommandations vaccinales 2020, https://vaccination-info-service.fr/var/vis/storage/original/application/download/calendrier_vaccinations_2020-2.pdf; 2020 [accessed 20 September 2020].
  91. [91].↵
    European Centre for Disease Prevention and Control. Public health guidance on HIV, hepatitis B and C testing in the EU/EEA, https://www.ecdc.europa.eu/sites/portal/files/documents/HIV-hepatitis-B-and-C-testing-public-health-guidance.pdf;2018 [accessed 20 September 2020].
Back to top
Posted November 01, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Vaccine-preventable diseases other than tuberculosis, and homelessness: A systematic review of the published literature, 1980 to 2020
Tran Duc Anh Ly, Sergei Castaneda, Van Thuan Hoang, Thi Loi Dao, Philippe Gautret
medRxiv 2020.10.28.20220335; doi: https://doi.org/10.1101/2020.10.28.20220335
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area